Risultati della ricerca - Thomas, Alissa

Essential competencies in palliative medicine for neuro-oncologists di Thomas, Alissa A., Carver, Alan

Testo Testo Testo

Immunotherapy for the Treatment of Glioblastoma di Thomas, Alissa A., Ernstoff, Marc S., Fadul, Camilo E.

Testo Testo Testo

QLIF-15. PERI-OPERATIVE RISK FACTORS FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH MALIGNANT GLIOMA di Wright, Heather, Douce, Daniel, Holmes, Chris, Thomas, Alissa

Testo Testo

Vaccine-based immunotherapy for glioblastoma di Thomas, Alissa A, Fisher, Jan L, Ernstoff, Marc S, Fadul, Camilo E

Testo Testo Testo

RARE-30. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH LEPTOMENINGEAL DISSEMINATION RESPONSIVE TO BRAF INHIBITION AND BEVACIZUMAB di Thomas, Alissa, Tucker, Suzanne, Nelson, Carl, Nickerson, Joshua, Durham, Susan, Homans, Alan

Testo Testo

EPID-07. ACCESS TO GLIOBLASTOMA CLINICAL TRIALS FOR RURAL PATIENTS IN THE UNITED STATES FROM 2010–2020 di Nevel, Kathryn, Capouch, Samuel, Arnold, Lisa, Peters, Katherine, Mohile, Nimish, Thomas, Alissa

Testo Testo

Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules di Virmani, Pooja, Chung, Esther, Thomas, Alissa A., Mellinghoff, Ingo K., Marchetti, Michael A.

Testo Testo Testo

Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Patient With Refractory Illness After 25 Months of Intensive Immunotherapy di Thomas, Alissa, Rauschkolb, Paula, Gresa-Arribas, Núria, Schned, Alan, Dalmau, Josep O., Fadul, Camilo E.

Testo Testo Testo

NI-74 DYNAMIC CONTRAST ENHANCED (DCE) T1 MRI PERFUSION DIFFERENTIATES PSEUDOPROGRESSION FROM RECURRENT GLIOBLASTOMA di Thomas, Alissa, Perez, Julio Arevalo, Peck, Kyung, Schneider, Taylor, Lyo, John, Young, Robert, Kaley, Thomas

Testo Testo

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab di Thomas, Alissa, Rosenblum, Marc, Karimi, Sasan, DeAngelis, Lisa M, Omuro, Antonio, Kaley, Thomas J

Testo Testo Testo

INNV-10. SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA di Thomas, Alissa, Wright, Heather, Walker, Hannah, Prasad, Prachi, Chan, Kelly, Tipirneni, Eswar, Goodwin, Andrew, Holmes, Chris

Testo Testo

Multifocal metastases to choroid plexus from papillary thyroid carcinoma: illustrative case di Beach, Isidora R., Olszewski, Adam M., Thomas, Alissa A., DeWitt, John C., Liebelt, Brandon D.

Testo Testo Testo

Intradural cauda equina Candida abscess presenting with hydrocephalus: case report di Argersinger, Davis P., Natkha, Vitaliy P., Shepard, Matthew J., Thomas, Alissa A., Oler, Andrew J., Williamson, Peter R., Chittiboina, Prashant, Heiss, John D.

Testo Testo Testo

CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS) di Sarai, Guneet, Amidon, Ryan F, Bovi, Joesph A, Thomas, Alissa A, Novicoff, Wendy, Schuetz, Samantha, Singh, Rohit, Chang, Amy, Sheehan, Jason P, Fadul, Camilo E

Testo Testo

Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients di Zhang, Myron, Gulotta, Bryanna, Thomas, Alissa, Kaley, Thomas, Karimi, Sasan, Gavrilovic, Igor, Woo, Kaitlin M., Zhang, Zhigang, Arevalo-Perez, Julio, Holodny, Andrei I., Rosenblum, Marc, Young, Robert J.

Testo Testo Testo

Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect di Ades, Steven, Herrera, Diego Adrianzen, Lahey, Tim, Thomas, Alissa A., Jasra, Sakshi, Barry, Maura, Sprague, Julian, Dittus, Kim, Plante, Timothy B., Kelly, Jamie, Kaufman, Peter A., Khan, Farrah, Hammond, Cory J., Gernander, Kelly, Parsons, Polly, Holmes, Chris

Testo Testo Testo

SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology di Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana

Testo Testo Testo

Regulatory T cells are not a strong predictor of survival for patients with glioblastoma di Thomas, Alissa A., Fisher, Jan L., Rahme, Gilbert J., Hampton, Thomas H., Baron, Udo, Olek, Sven, Schwachula, Tim, Rhodes, C. Harker, Gui, Jiang, Tafe, Laura J., Tsongalis, Gregory J., Lefferts, Joel A., Wishart, Heather, Kleen, Jonathan, Miller, Michael, Whipple, Chery A., de Abreu, Francine B., Ernstoff, Marc S., Fadul, Camilo E.

Testo Testo Testo

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma di Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.

Testo Testo Testo

COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT di Mrugala, Maciej, Ostrom, Quinn, Pressley, Shelley, Thomas, Alissa, Wefel, Jeffrey S, Coven, Scott, Acquaye, Alvina, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine, Butowski, Nicholas, Hervey-Jumper, Shawn, Porter, Alyx, Oliver, Kathy, Dunbar, Erin, Taylor, Jennie, Schiff, David, Nassiri, Farshad, Hegi, Monika, Armstrong, Terri, van den Bent, Martin, Chang, Susan, Zadeh, Gelareh, Chheda, Milan

Testo Testo